Reviving protease inhibitors: New data and more options

被引：0

作者：

Murphy, RL ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

来源：

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2003年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：S43 / +

页数：13

共 50 条

[1] New anti-HIV protease inhibitors provide more treatment options
Nadler, J
[J]. AIDS PATIENT CARE AND STDS, 2003, 17 (11) : 551 - 564
[2] HCV protease inhibitors bring new options for patients
Traynor, Kate
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (15) : 1372 - +
[3] HIV protease inhibitors as new treatment options for Kaposi's sarcoma
Barillari, G
Sgadari, C
Toschi, E
Monini, P
Ensoli, B
[J]. DRUG RESISTANCE UPDATES, 2003, 6 (04) : 173 - 181
[4] More on protease inhibitors and lipids
Barza, M
[J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2000, 9 (02) : 41 - 41
[5] Atazanavir:: The advent of a new generation of more convenient protease inhibitors
Barreiro, P
Rendón, A
Ródriguez-Nóvoa, S
Soriano, V
[J]. HIV CLINICAL TRIALS, 2005, 6 (01): : 50 - 61
[6] HIV protease inhibitors: More evidence of effectiveness
Cimons, M
[J]. ASM NEWS, 1996, 62 (04): : 178 - 179
[7] Two more HIV protease inhibitors approved
Fox, JL
[J]. NATURE BIOTECHNOLOGY, 1996, 14 (04) : 427 - 427
[8] Do new protease inhibitors offer improved sequencing options? Issues of PI resistance and sequencing
Hsu, RK
Wainberg, MA
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 : S13 - S21
[9] Do new protease inhibitors offer improved management options? Issues of PI tolerability and safety
Sax, PE
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 : S22 - S34
[10] Protease inhibitors - The new alternative?
Moyle, Graeme
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 : S4 - S4

← 1 2 3 4 5 →